6878
S. Furuya, S. Terashima / Tetrahedron Letters 44 (2003) 6875–6878
(i). Thus, it had been reported that oxidation of i with 8
or 9 gives ii corresponding to ent-5 (Ref. 5).
9. The optical purity of 5 and ent-5 was rigorously deter-
mined by HPLC analysis with a chiral column (Daicel
Chiralcel OD-H, i-PrOH/hexane 90/10, flow rate 0.5
ml/min, tR 22.8 min (5) and 24.2 min (ent-5), detection at
254 nm).
10. Davis et al. reported that, depending upon the structure
of the ketonic substrate, (+)-[(8,8-dichlorocam-
phoryl)sulfonyl]oxazoridine (9) sometimes gives a chiral
alcohol which is more highly optically active than that
produced by using 8 (Ref. 5).
Figure 3. Structure of (+)-illicinone A (12).
the key steps. Considering its directness and flexibility,
the explored synthetic scheme may be amenable to a
large-scale preparation of 1 as well as applicable to
synthesis of various structural types of novel congeners
of 1. Additionally, our first total synthesis of an enan-
tiomerc pair of optically pure 1 disclosed an interesting
feature concerning the optical purity of a natural sam-
ple of 1.
11. The reaction mechanism of asymmetric hydroxylation
which, for example, provides ii and iv from i and iii,
respectively, has not hitherto been presented by Davis et
al. (Ref. 5).
Acknowledgements
12. Summing up the results collected by our studies on
asymmetric hydroxylation, it appeared that 6 should be
considered structurally more close to the 2-methoxylcar-
bonyl-1-tetralone iii than to i since iii gives iv when
oxidized with 8 or 9 (Ref. 5).
The authors are grateful to Professor Y. Fukuyama,
Faculty of Pharmaceutical Sciences, Tokushima Bunri
1
University, for providing copies of H and 13C NMR
spectra of natural 1 and for many valuable suggestions.
References
1. Fukuyama, Y.; Shida, N.; Kodama, M.; Chaki, M.;
Yugami, T. Chem. Pharm. Bull. 1995, 43, 2270.
2. (a) Yoshida, M.; Hasegawa, M.; Noda, Y.; Nabeshima,
T. Dementia 1995, 9, 233; (b) Davies, P. Brain Res. 1979,
171, 319; (c) Takadoi, M.; Katoh, T.; Ishiwata, A.;
Terashima, S. Tetrahedron 2002, 58, 9903.
3. Kaneko, I.; Iwata, N. Farmashia 2001, 37, 501.
4. (a) Pettus, T. R. R.; Chen, X.-T.; Danishefsky, S. J. J.
Am. Chem. Soc. 1998, 120, 12684; (b) Pettus, T. R. R.;
Inoue, M.; Chen, X.-T.; Danishefsky, S. J. J. Am. Chem.
Soc. 2000, 122, 6160.
5. (a) Davis, F. A.; Sheppard, A. C. Tetrahedron 1989, 45,
5703; (b) Davis, F. A.; Weismiller, M. C. J. Org. Chem.
1990, 55, 3715; (c) Davis, F. A.; Sheppard, A. C.; Chen,
B.-C.; Haque, M. S. J. Am. Chem. Soc. 1990, 112, 6679;
(d) Davis, F. A.; Kumar, A.; Chen, B.-C. J. Org. Chem.
1991, 56, 1143; (e) Chen, B.-C.; Murphy, C. K.; Kumar,
A.; Reddy, R. T.; Clark, C.; Zhou, P.; Lews, B. M.; Gala,
D.; Mergelsberg, I.; Scherer, D.; Buckley, J.; Di
Benadetto, D.; Davis, F. A. Org. Synth. 1996, 73, 159.
6. (a) Ishizaki, M.; Iwahara, K.; Niimi, Y.; Satoh, H.;
Hoshino, O. Tetrahedron 2001, 57, 2729; (b) Flethcer, A.
J.; Christie, D. R. J. Chem. Soc., Perkin Trans. 1 2000,
1657; (c) Brummond, K. M.; Kent, J. L. Tetrahedron
2000, 56, 3263; (d) Sugihara, T. Kagaku 1999, 54, 58.
7. Toyota, M.; Yokota, M.; Ihara, M. J. Am. Chem. Soc.
2001, 123, 1856.
13. The optical purity of 4 and ent-4 was rigorously deter-
mined by HPLC analysis with a chiral column (Daicel
Chiralcel OD-H, i-PrOH/hexane 97.5/2.5, flow rate 1.0
ml/min, tR 25.7 min (4) and 26.8 min (ent-4), detection at
254 nm).
14. Ng, F. W.; Danishefsky, S. J. J. Am. Chem. Soc. 2002,
124, 9812.
15. The relative stereochemistry of this compound was defin-
itely determined by single-crystal X-ray analysis. See:
Furuya, S.; Ijuin, Y.; Terashima, S., to be published.
16. Metha, G.; Sreenivas, K. Chem. Commun. 2001, 1892.
17. Fitjer, L.; Quabeck, U. Synth. Commun. 1985, 15, 855.
18. The optical purity of 1 and ent-1 was definitely deter-
mined by HPLC analysis with a chiral column (Daicel
Chiralcel AD-H, i-PrOH/hexane 90/10, flow rate 0.5
ml/min, tR 13.5 min (1) and 14.5 min (ent-1), detection at
254 nm).
19. The melting point of the synthetic racemic sample for 1
was not reported in Ref. 4b.
20. Yakushiji, K.; Tohshima, T.; Kitagawa, E.; Suzuki, R.;
Sekikawa, J.; Morishita, T.; Murata, H.; Lu, S.-T.;
Furukawa, H. Chem. Pharm. Bull. 1984, 32, 11.
21. Direct comparison of natural and synthetic 1 by HPLC
analysis18 could not be performed since the natural sam-
ple had been completely consumed for biological studies
(personal communication from Professor Y. Fukuyama).
8. (−)-(Camphorylsulfonyl)oxazoridine (ent-8) was utilized
as a chiral oxidant of the first choice by considering the
structural similarity between 6 and 2-methyl-1-tetralone